Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia

Headache

Volumn 54, Issue 3, 2014, Pages 472-484

  Raddant, Ann C ^a   Russo, Andrew F ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

calcitonin gene related peptide; migraine; procalcitonin; reactive oxygen species; trigeminal ganglion

Indexed keywords

CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; MESSENGER RNA; PROCALCITONIN; REACTIVE OXYGEN METABOLITE; TEMPOL; PROTEIN PRECURSOR;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPLANT; GENE EXPRESSION; GENE INDUCTION; GLIA; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MIGRAINE; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROGENIC INFLAMMATION; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIGEMINUS GANGLION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MIGRAINE DISORDERS; NEUROGLIA; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGEMINAL GANGLION;

EID: 84895861224     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12301     Document Type: Article

References (68)

1. Ray BS, Wolff HG,. Experimental studies on headache-Pain-sensitive structures of the head and their significance in headache. Arch Surg-Chicago. 1940; 41: 813-856.
2. Noseda R, Jakubowski M, Kainz V, Borsook D, Burstein R,. Cortical projections of functionally identified thalamic trigeminovascular neurons: Implications for migraine headache and its associated symptoms. J Neurosci. 2011; 31: 14204-14217.
3. Edvinsson L,. Tracing neural connections to pain pathways with relevance to primary headaches. Cephalalgia. 2011; 31: 737-747.
4. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
5. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P,. Origin of pain in migraine: Evidence for peripheral sensitisation. Lancet Neurol. 2009; 8: 679-690.
6. Markowitz S, Saito K, Moskowitz MA,. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci. 1987; 7: 4129-4136.
7. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I,. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985; 313: 54-56.
8. Villalon CM, Olesen J,. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther. 2009; 124: 309-323.
9. Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003; 106: 461-470.
10. Goadsby PJ, Edvinsson L, Ekman R,. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990; 28: 183-187.
11. Tfelt-Hansen P, Le H,. Calcitonin gene-related peptide in blood: Is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain. 2009; 10: 137-143.
12. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J,. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol. 2005; 58: 561-568.
13. Hansen JM, Hauge AW, Olesen J, Ashina M,. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010; 30: 1179-1186.
14. Connor KM, Shapiro RE, Diener HC, et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology. 2009; 73: 970-977.
15. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004; 350: 1104-1110.
16. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr,. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004; 89: 1512-1525.
17. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM,. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982; 298: 240-244.
18. Domenech VS, Nylen ES, White JC, et al. Calcitonin gene-related peptide expression in sepsis: Postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Investig Med. 2001; 49: 514-521.
19. Sexton PM, Christopoulos G, Christopoulos A, Nylen ES, Snider RH Jr, Becker KL,. Procalcitonin has bioactivity at calcitonin receptor family complexes: Potential mediator implications in sepsis. Crit Care Med. 2008; 36: 1637-1640.
20. Buhaescu I, Yood RA, Izzedine H,. Serum procalcitonin in systemic autoimmune diseases-where are we now? Semin Arthritis Rheum. 2010; 40: 176-183.
21. Turan H, Horasanli B, Ugur M, Arslan H,. Procalcitonin levels in migraine patients. Can J Neurol Sci. 2011; 38: 124-128.
22. Eftekhari S, Edvinsson L,. Possible sites of action of the new calcitonin gene-related peptide receptor antagonists. Ther Adv Neurol Disord. 2010; 3: 369-378.
23. Park KY, Russo AF,. Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons. J Biol Chem. 2008; 283: 5441-5451.
24. Park KY, Fletcher JR, Raddant AC, Russo AF,. Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia. 2011; 31: 614-624.
25. Linscheid P, Seboek D, Zulewski H, Keller U, Muller B,. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology. 2005; 146: 2699-2708.
26. Bowen EJ, Schmidt TW, Firm CS, Russo AF, Durham PL,. Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem. 2006; 96: 65-77.
27. Kristiansen KA, Edvinsson L,. Neurogenic inflammation: A study of rat trigeminal ganglion. J Headache Pain. 2010; 11: 485-495.
28. Tajti J, Kuris A, Vecsei L, Xu CB, Edvinsson L,. Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia. 2011; 31: 95-105.
29. Dapson RW,. Macromolecular changes caused by formalin fixation and antigen retrieval. Biotech Histochem. 2007; 82: 133-140.
30. Zhang L, Hoff AO, Wimalawansa SJ,. Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain. 2001; 89: 265-273.
31. Xie W, Fisher JT, Lynch TJ, et al. CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice. J Clin Invest. 2011; 121: 3144-3158.
32. Mullen RJ, Buck CR, Smith AM,., NeuN, a neuronal specific nuclear protein in vertebrates. Development. 1992; 116: 201-211.
33. Spano AJ, Frankfurter A,. Characterization of anti-beta-tubulin antibodies. Methods Cell Biol. 2010; 95: 33-46.
34. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408.
35. Jessen KR, Morgan L, Stewart HJ, Mirsky R,. Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: Development and regulation by neuron-Schwann cell interactions. Development. 1990; 109: 91-103.
36. Belzer V, Shraer N, Hanani M,. Phenotypic changes in satellite glial cells in cultured trigeminal ganglia. Neuron Glia Biol. 2010; 6: 237-243.
37. Zangar RC, Bollinger N, Weber TJ,. Reactive oxygen species alter autocrine and paracrine signaling. Free Radic Biol Med. 2011; 51: 2041-2047.
38. Bucana CD, Giavazzi R, Nayar R, et al. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants. Exp Cell Res. 1990; 190: 69-75.
39. Bolay H, Reuter U, Dunn AK,. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8: 136-142.
40. Zhang X, Levy D, Noseda R,. Activation of meningeal nociceptors by cortical spreading depression: Implications for migraine with aura. J Neurosci. 2010; 30: 8807-8814.
41. Dalkara T, Zervas NT, Moskowitz MA,. From spreading depression to the trigeminovascular system. Neurol Sci. 2006; 27 (Suppl. 2): S86-S90.
42. Durham PL, Russo AF,. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci. 2003; 23: 807-815.
43. Durham PL, Russo AF,. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol Endocrinol. 1998; 12: 1002-1009.
44. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J,. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis. 2004; 39: 206-217.
45. Lateef A, Khoo SM, Lee KH,. Procalcitonin in hypoxic brain damage. Intensive Care Med. 2005; 31: 494.
46. Nylen ES, Whang KT, Snider RH Jr,. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998; 26: 1001-1006.
47. Annborn M, Dankiewicz J, Erlinge D, et al. Procalcitonin after cardiac arrest-An indicator of severity of illness, ischemia-reperfusion injury and outcome. Resuscitation. 2013; 84: 782-787.
48. Araujo M, Doi SQ, Palant CE, Nylen ES, Becker KL,. Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: Implications for septic renal injury. Inflamm Res. 2013; 62: 887-894.
49. Liappis AP, Gibbs KW, Nylen ES, et al. Exogenous procalcitonin evokes a pro-inflammatory cytokine response. Inflamm Res. 2011; 60: 203-207.
50. Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006; 46: 200-207.
51. Diener HC, Lampl C, Reimnitz P, Voelker M,. Aspirin in the treatment of acute migraine attacks. Expert Rev Neurother. 2006; 6: 563-573.
52. Silberstein SD, Goadsby PJ,. Migraine: Preventive treatment. Cephalalgia. 2002; 22: 491-512.
53. Ooi L, Gigout S, Pettinger L, Gamper N,. Triple cysteine module within M-type K + channels mediates reciprocal channel modulation by nitric oxide and reactive oxygen species. J Neurosci. 2013; 33: 6041-6046.
54. Shatillo A, Koroleva K, Giniatullina R, et al. Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system. Neuroscience. 2013; 253: 341-349.
55. Viggiano A, Viggiano E, Valentino I,. Cortical spreading depression affects reactive oxygen species production. Brain Res. 2011; 1368: 11-18.
56. Tozzi A, de Iure A, Di Filippo M, et al. Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. Proc Natl Acad Sci U S A. 2012; 109: 18985-18990.
57. Colonna DM, Meng W, Deal DD, Busija DW,. Calcitonin gene-related peptide promotes cerebrovascular dilation during cortical spreading depression in rabbits. Am J Physiol. 1994; 266: H1095-H1102.
58. Olesen J, Thomsen LL, Iversen H,. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharm Sci. 1994; 15: 149-153.
59. Chen Z, Foster MW, Zhang J, et al. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A. 2005; 102: 12159-12164.
60. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V,. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000; 20: 907-918.
61. Cao X, Demel SL, Quinn MT, Galligan JJ, Kreulen D,. Localization of NADPH oxidase in sympathetic and sensory ganglion neurons and perivascular nerve fibers. Auton Neurosci. 2009; 151: 90-97.
62. Linley JE, Ooi L, Pettinger L, et al. Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neurons. Proc Natl Acad Sci U S A. 2012; 109: E1578-E1586.
63. Lee Y, Takami K, Kawai Y, et al. Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience. 1985; 15: 1227-1237.
64. Skofitsch G, Jacobowitz DM,. Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides. 1985; 6: 747-754.
65. Zhang Z, Winborn CS, Marquez, de Prado B, Russo AF,. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci. 2007; 27: 2693-2703.
66. Magalhaes J, Ascensao A, Soares JM, et al. Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. J Appl Physiol. 2005; 99: 1247-1253.
67. Takano T, Tian GF, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007; 10: 754-762.
68. Schoonman GG, Sandor PS, Agosti RM, et al. Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia. 2006; 26: 816-819.